Upstream Bio (UPB) Net Margin (2023 - 2025)
Historic Net Margin for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to 4941.14%.
- Upstream Bio's Net Margin fell 14760700.0% to 4941.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 4386.35%, marking a year-over-year decrease of 12332500.0%. This contributed to the annual value of 3223.42% for FY2024, which is 16160600.0% down from last year.
- Upstream Bio's Net Margin amounted to 4941.14% in Q3 2025, which was down 14760700.0% from 4265.31% recorded in Q2 2025.
- Upstream Bio's 5-year Net Margin high stood at 1006.92% for Q3 2023, and its period low was 4941.14% during Q3 2025.
- Its 3-year average for Net Margin is 3489.52%, with a median of 3554.65% in 2024.
- Its Net Margin has fluctuated over the past 5 years, first plummeted by -2248700bps in 2024, then plummeted by -26289600bps in 2025.
- Upstream Bio's Net Margin (Quarter) stood at 3329.78% in 2023, then fell by -7bps to 3554.65% in 2024, then tumbled by -39bps to 4941.14% in 2025.
- Its last three reported values are 4941.14% in Q3 2025, 4265.31% for Q2 2025, and 4818.02% during Q1 2025.